Insider Transactions last 24 months for Dyne Therapeutics, Inc.  -  NSDQ: DYN

 
Transactions
All Buy Sell Option Exercise
Filer's Name
Relationship/
Title
Trans.
Date
Trans. Type
Ownership Type
Security Type
Shares
Price
Trans.
Value
Total Shares Owned
Kerr DouglasChief Medical Officer09/05/2025DSDirectCOM873$13.41$11,706.9388,390
Friedl-Naderer JohannaChief Commercial Officer09/05/2025DSDirectCOM144$13.41$1,931.0494,873
Cox JohnCEO & President09/05/2025DSDirectCOM2,640$13.41$35,402.40199,539
Kerr DouglasChief Medical Officer09/04/2025DSDirectCOM3,552$13.27$47,135.0489,263
Friedl-Naderer JohannaChief Commercial Officer09/04/2025DSDirectCOM894$13.27$11,863.3895,017
Cox JohnCEO & President07/15/2025DGDirectCOM10,000$0.00$0.00202,179
Cox JohnCEO & President07/15/2025DGDirectCOM10,000$0.00$0.00212,179
Cox JohnCEO & President07/15/2025DGDirectCOM10,000$0.00$0.00222,179
Cox JohnCEO & President07/15/2025DGDirectCOM10,000$0.00$0.00232,179
Cox JohnCEO & President07/14/2025APDirectCOM100,000$9.11$911,000.00242,179
Friedl-Naderer JohannaChief Commercial Officer06/05/2025DSDirectCOM146$13.35$1,949.1095,911
Kerr DouglasChief Medical Officer06/05/2025DSDirectCOM1,342$13.35$17,915.7092,815
Cox JohnCEO & President06/05/2025DSDirectCOM4,060$13.35$54,201.00142,179
Lucera ErickChief Financial Officer03/31/2025AADirectCOM66,100$0.00$0.0066,100
Friedl-Naderer JohannaChief Commercial Officer03/13/2025DSDirectCOM143$12.12$1,733.1696,057
Beskrovnaya OxanaChief Scientific Officer03/11/2025DSDirectCOM2,153$11.38$24,501.14195,840
Scalzo Richard WilliamSVP, Head of Finance & Admin.03/11/2025DSDirectCOM1,343$11.38$15,283.34122,330
Beskrovnaya OxanaChief Scientific Officer03/05/2025DSDirectCOM1,094$11.83$12,942.02197,993
Scalzo Richard WilliamSVP, Head of Finance & Admin.03/05/2025DSDirectCOM917$11.83$10,848.11123,673
Cox JohnCEO & President03/05/2025DSDirectCOM4,061$11.83$48,041.63146,239
Kerr DouglasChief Medical Officer03/05/2025DSDirectCOM1,343$11.83$15,887.6994,157
Scalzo Richard WilliamSVP, Head of Finance & Admin.02/18/2025DSDirectCOM2,488$13.95$34,707.60124,590
Beskrovnaya OxanaChief Scientific Officer02/18/2025DSDirectCOM2,598$13.95$36,242.10199,087
Rhodes Jason PDirector01/27/2025AAIndirectCOM1,111,111$13.50$14,999,998.501,958,427
Scalzo Richard WilliamSVP, Head of Finance & Admin.12/11/2024DSDirectCOM1,455$28.12$40,914.60127,078
1   2  3  4  5  6  7  8  9  10  Next Last  You are at page 1 of 13 pages
Transaction Type Key
First letter: A = Acquired, D = Disposed
Second letter:
A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust 		Export Table Data to Excel Send to Excel